Summary & Overview
HCPCS G9806: Cervical Cytology or HPV Test
HCPCS Level II code G9806 designates patients who received cervical cytology (Pap) or an HPV test. This screening-related code is important nationally because cervical cancer prevention and early detection programs rely on standardized reporting of testing encounters to track screening rates, quality measures, and access to preventive services. Consistent use of G9806 supports quality measurement, public health monitoring, and payer reporting workflows.
Key payers included in coverage considerations are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical service settings, and the clinical context for cervical cytology and HPV testing. The publication outlines common modifiers and payer considerations provided in the input, notes where input data are not available, and summarizes related billing and reporting implications.
This piece provides benchmarks and policy-relevant context for billing and quality reporting, clarifies the service line and sites where the code is typically used, and points to areas where additional documentation or payer-specific guidance may be needed. Data not available in the input are clearly identified.
Billing Code Overview
HCPCS Level II code G9806 reports patients who received cervical cytology or an HPV test. This represents preventive and diagnostic screening for cervical cancer and human papillomavirus infection.
-
Service type: Cervical cytology (Pap test) or HPV testing performed to screen or evaluate cervical pathology.
-
Typical site of service: Outpatient clinics, primary care offices, women's health clinics, and laboratory facilities where cervical screening specimens are collected or processed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 32-year-old woman presents to a primary care or women's health clinic for routine cervical cancer screening. She is asymptomatic, sexually active, and due for screening per guidelines. The clinician performs a speculum exam, obtains a cervical sampling for liquid-based cytology (Pap test) and reflex or co-testing with high-risk human papillomavirus (HPV) testing as indicated by age and guideline status. The specimen is labeled and sent to the pathology laboratory, and the visit includes documentation of informed consent for cervical cytology/HPV testing, specimen source, collection method, and any relevant clinical history (e.g., prior abnormal results, immunosuppression, pregnancy). Typical workflow spans outpatient ambulatory care settings such as a primary care clinic, family medicine, obstetrics and gynecology clinic, or community health center. Billing uses HCPCS Level II code G9806 to indicate that the patient received cervical cytology or an HPV test; results drive subsequent management (surveillance, colposcopy referral, treatment) depending on cytology and HPV findings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work required to collect the specimen is substantially greater than usual (rare for routine Pap/HPV but possible with extensive additional counseling or complex collection). |